Radiation Oncology Journal

  • 제35권3호
  • /
  • Pages.241-248
  • /
  • 2017
  • /
  • 2234-1900(pISSN)
  • /
  • 2234-3156(eISSN)
대한방사선종양학회 (The Korean Society for Radiation Oncology)
권호 표지
DOI QR코드

DOI QR Code

Treatment outcomes of extended-field radiation therapy for thoracic superficial esophageal cancer

  • Lee, Doo Yeul (Proton Therapy Center, Research Institute and Hospital, National Cancer Center) ;
  • Moon, Sung Ho (Proton Therapy Center, Research Institute and Hospital, National Cancer Center) ;
  • Cho, Kwan Ho (Proton Therapy Center, Research Institute and Hospital, National Cancer Center) ;
  • Kim, Tae Hyun (Proton Therapy Center, Research Institute and Hospital, National Cancer Center) ;
  • Kim, Moon Soo (Center for Lung Cancer, Research Institute and Hospital, National Cancer Center) ;
  • Lee, Jong Yeul (Center for Lung Cancer, Research Institute and Hospital, National Cancer Center) ;
  • Suh, Yang-Gun (Proton Therapy Center, Research Institute and Hospital, National Cancer Center)
  • 투고 : 2017.09.14
  • 심사 : 2017.09.20
  • 발행 : 2017.09.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Purpose: To evaluate the efficacy and safety of extended-field radiation therapy for patients with thoracic superficial esophageal cancer (SEC). Materials and Methods: From May 2007 to October 2016, a total of 24 patients with thoracic SEC (T1a and T1b) who underwent definitive radiotherapy and were analyzed retrospectively. The median total radiotherapy dose was 64 Gy (range, 54 to 66 Gy) in conventional fractionation. All 24 patients received radiotherapy to whole thoracic esophagus and 23 patients received elective nodal irradiation. The supraclavicular lymph nodes, the celiac lymph nodes, and both of those nodal areas were included in 11, 3, and 9 patients, respectively. Results: The median follow-up duration was 28.7 months (range 7.9 to 108.0 months). The 3-year overall survival, local control, and progression-free survival rates were 95.2%, 89.7%, and 78.7%, respectively. There were 5 patients (20.8%) with progression of disease, 2 local failures (8.3%) and 3 (12.5%) regional failures. Three patients also experienced distant metastasis and had died of disease progression. There were no treatment-related toxicities of grade 3 or higher. Conclusion: Definitive extended-field radiotherapy for thoracic SEC showed durable disease control rates in medically inoperable and endoscopically unfit patients. Even extended-field radiotherapy with elective nodal irradiation was safe without grade 3 or 4 toxicities.

키워드

참고문헌

  1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917. https://doi.org/10.1002/ijc.25516
  2. Kumagai Y, Monma K, Kawada K. Magnifying chromoendoscopy of the esophagus: in-vivo pathological diagnosis using an endocytoscopy system. Endoscopy 2004;36:590-4. https://doi.org/10.1055/s-2004-814533
  3. Yoshida T, Inoue H, Usui S, Satodate H, Fukami N, Kudo SE. Narrow-band imaging system with magnifying endoscopy for superficial esophageal lesions. Gastrointest Endosc 2004;59:288-95. https://doi.org/10.1016/S0016-5107(03)02532-X
  4. Tachimori Y, Ozawa S, Numasaki H, et al. Comprehensive registry of esophageal cancer in Japan, 2009. Esophagus 2016;13:110-137. https://doi.org/10.1007/s10388-016-0531-y
  5. Oyama T, Tomori A, Hotta K, et al. Endoscopic submucosal dissection of early esophageal cancer. Clin Gastroenterol Hepatol 2005;3(7 Suppl 1):S67-70. https://doi.org/10.1016/S1542-3565(05)00291-0
  6. Lee HJ, Lee H, Park JC, Shin SK, Lee SK, Lee YC. Treatment strategy after endoscopic resection of superficial esophageal squamous cell carcinoma: a single institution experience. Gut Liver 2015;9:714-9.
  7. Yamashina T, Ishihara R, Nagai K, et al. Long-term outcome and metastatic risk after endoscopic resection of superficial esophageal squamous cell carcinoma. Am J Gastroenterol 2013;108:544-51. https://doi.org/10.1038/ajg.2013.8
  8. Griffin SM, Shaw IH, Dresner SM. Early complications after Ivor Lewis subtotal esophagectomy with two-field lymphadenectomy: risk factors and management. J Am Coll Surg 2002;194:285-97. https://doi.org/10.1016/S1072-7515(01)01177-2
  9. Tachibana M, Kinugasa S, Yoshimura H, et al. Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma. Am J Surg 2005;189:98-109. https://doi.org/10.1016/j.amjsurg.2004.10.001
  10. Nemoto K, Yamada S, Nishio M, et al. Results of radiation therapy for superficial esophageal cancer using the standard radiotherapy method recommended by the Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group. Anticancer Res 2006;26:1507-12.
  11. Ariga T, Ogawa K, Shimoji H, et al. Radical radiotherapy for superficial esophageal cancer: impact of clinical N stage on survival. Anticancer Res 2012;32:3371-6.
  12. Murakami Y, Nagata Y, Nishibuchi I, et al. Long-term outcomes of intraluminal brachytherapy in combination with external beam radiotherapy for superficial esophageal cancer. Int J Clin Oncol 2012;17:263-71. https://doi.org/10.1007/s10147-011-0285-4
  13. Oh D, Noh JM, Nam H, Lee H, Kim TG, Ahn YC. High-dose radiation therapy alone by moderate hypofractionation for patients with thoracic esophageal squamous cell carcinoma. Medicine (Baltimore) 2016;95:e4591. https://doi.org/10.1097/MD.0000000000004591
  14. Endo M, Yoshino K, Kawano T, Nagai K, Inoue H. Clinicopathologic analysis of lymph node metastasis in surgically resected superficial cancer of the thoracic esophagus. Dis Esophagus 2000;13:125-9. https://doi.org/10.1046/j.1442-2050.2000.00100.x
  15. Shimada H, Nabeya Y, Matsubara H, et al. Prediction of lymph node status in patients with superficial esophageal carcinoma: analysis of 160 surgically resected cancers. Am J Surg 2006;191:250-4. https://doi.org/10.1016/j.amjsurg.2005.07.035
  16. Wang GQ, Jiao GG, Chang FB, et al. Long-term results of operation for 420 patients with early squamous cell esophageal carcinoma discovered by screening. Ann Thorac Surg 2004;77:1740-4. https://doi.org/10.1016/j.athoracsur.2003.10.098
  17. Tachibana M, Hirahara N, Kinugasa S, Yoshimura H. Clinicopathologic features of superficial esophageal cancer: results of consecutive 100 patients. Ann Surg Oncol 2008;15:104-16. https://doi.org/10.1245/s10434-007-9604-4
  18. Shimizu Y, Tsukagoshi H, Fujita M, Hosokawa M, Kato M, Asaka M. Long-term outcome after endoscopic mucosal resection in patients with esophageal squamous cell carcinoma invading the muscularis mucosae or deeper. Gastrointest Endosc 2002;56:387-90. https://doi.org/10.1016/S0016-5107(02)70043-6
  19. Akutsu Y, Uesato M, Shuto K, et al. The overall prevalence of metastasis in T1 esophageal squamous cell carcinoma: a retrospective analysis of 295 patients. Ann Surg 2013;257:1032-8. https://doi.org/10.1097/SLA.0b013e31827017fc
  20. Moraca RJ, Low DE. Outcomes and health-related quality of life after esophagectomy for high-grade dysplasia and intramucosal cancer. Arch Surg 2006;141:545-51. https://doi.org/10.1001/archsurg.141.6.545
  21. Viklund P, Wengstrom Y, Rouvelas I, Lindblad M, Lagergren J. Quality of life and persisting symptoms after oesophageal cancer surgery. Eur J Cancer 2006;42:1407-14. https://doi.org/10.1016/j.ejca.2006.02.005
  22. Koide Y, Kodaira T, Tachibana H, et al. Clinical outcome of definitive radiation therapy for superficial esophageal cancer. Jpn J Clin Oncol 2017;47:393-400. https://doi.org/10.1093/jjco/hyx021
  23. Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999;281:1623-7.
  24. Minsky BD, Pajak TF, Ginsberg RJ, et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combinedmodality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 2002;20:1167-74. https://doi.org/10.1200/JCO.2002.20.5.1167
  25. Ma JB, Song YP, Yu JM, et al. Feasibility of involved-field conformal radiotherapy for cervical and upper-thoracic esophageal cancer. Onkologie 2011;34:599-604. https://doi.org/10.1159/000334194
  26. Nakagawa S, Kanda T, Kosugi S, Ohashi M, Suzuki T, Hatakeyama K. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy. J Am Coll Surg 2004;198:205-11. https://doi.org/10.1016/j.jamcollsurg.2003.10.005
  27. Huang W, Li B, Gong H, et al. Pattern of lymph node metastases and its implication in radiotherapeutic clinical target volume in patients with thoracic esophageal squamous cell carcinoma: a report of 1077 cases. Radiother Oncol 2010;95:229-33. https://doi.org/10.1016/j.radonc.2010.01.006

피인용 문헌

  1. Increased Efficiency of Range Verification in Routine QA for Pencil-Beam Scanning Proton Therapy vol.73, pp.7, 2018, https://doi.org/10.3938/jkps.73.983
  2. Development of a Daily-Treatment Beam-Monitoring System Based Gafchromic EBT3 Film for Pencil-Beam Scanning Proton Therapy vol.76, pp.8, 2017, https://doi.org/10.3938/jkps.76.769
  3. The Role of Modern Radiotherapy Technology in the Treatment of Esophageal Cancer vol.53, pp.4, 2017, https://doi.org/10.5090/kjtcs.2020.53.4.184